Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas

被引：16

作者：

Pileri, Stefano A. ^{[1
]}

Tripodo, Claudio ^{[2
,3
]}

Melle, Federica ^{[1
]}

Motta, Giovanna ^{[1
]}

Tabanelli, Valentina ^{[1
]}

Fiori, Stefano ^{[1
]}

Vegliante, Maria Carmela ^{[4
]}

Mazzara, Saveria ^{[1
]}

Ciavarella, Sabino ^{[4
]}

Derenzini, Enrico ^{[5
,6
]}

机构：

[1] IEO IRCCS, European Inst Oncol, Div Haematopathol, Via Ripamonti 435, I-20141 Milan, Italy

[2] Univ Palermo, Tumor Immunol Unit, I-90133 Palermo, Italy

[3] FIRC Inst Mol Oncol, Tumor & Microenvironm Histopathol Unit, IFOM, I-20139 Milan, Italy

[4] IRCCS, Hematol & Cell Therapy Unit, Ist Tumori Giovanni Paolo II, Viale Flacco 65, I-70124 Bari, Italy

[5] IEO IRCCS, European Inst Oncol, Div Haematooncol, Via Ripamonti 435, I-20141 Milan, Italy

[6] Univ Milan, Dept Hlth Sci, Via Rudini 8, I-20146 Milan, Italy

来源：

CELLS | 2021年 / 10卷 / 03期

关键词：

diffuse large B-cell lymphoma; gene expression profiling; next-generation sequencing; classification; diagnosis; prognosis; therapy; GENE-EXPRESSION; CLINICAL IMPACT; CLASSIFICATION; ORIGIN; SURVIVAL; CHOP; SIGNATURES; CHEMOTHERAPY; SUBTYPES; PROFILE;

D O I：

10.3390/cells10030675

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Diffuse large B-cell lymphoma (DLBCL) is the commonest form of lymphoid malignancy, with a prevalence of about 40% worldwide. Its classification encompasses a common form, also termed as "not otherwise specified" (NOS), and a series of variants, which are rare and at least in part related to viral agents. Over the last two decades, DLBCL-NOS, which accounts for more than 80% of the neoplasms included in the DLBCL chapter, has been the object of an increasing number of molecular studies which have led to the identification of prognostic/predictive factors that are increasingly entering daily practice. In this review, the main achievements obtained by gene expression profiling (with respect to both neoplastic cells and the microenvironment) and next-generation sequencing will be discussed and compared. Only the amalgamation of molecular attributes will lead to the achievement of the long-term goal of using tailored therapies and possibly chemotherapy-free protocols capable of curing most (if not all) patients with minimal or no toxic effects.

引用

页码：1 / 15

页数：15

共 61 条

[1] Significance of stromal-1 and stromal-2 signatures and biologic prognostic model in diffuse large B-cell lymphoma [J].

Abdou, Asmaa Gaber ;

Asaad, Nancy ;

Kandil, Mona ;

Shabaan, Mohammed ;

Shams, Asmaa .

CANCER BIOLOGY & MEDICINE, 2017, 14 (02) :151-161

[2] Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].

Alizadeh, AA ;

Eisen, MB ;

Davis, RE ;

Ma, C ;

Lossos, IS ;

Rosenwald, A ;

Boldrick, JG ;

Sabet, H ;

Tran, T ;

Yu, X ;

Powell, JI ;

Yang, LM ;

Marti, GE ;

Moore, T ;

Hudson, J ;

Lu, LS ;

Lewis, DB ;

Tibshirani, R ;

Sherlock, G ;

Chan, WC ;

Greiner, TC ;

Weisenburger, DD ;

Armitage, JO ;

Warnke, R ;

Levy, R ;

Wilson, W ;

Grever, MR ;

Byrd, JC ;

Botstein, D ;

Brown, PO ;

Staudt, LM .

NATURE, 2000, 403 (6769) :503-511

[3] Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment [J].

Alizadeh, Ash A. ;

Gentles, Andrew J. ;

Alencar, Alvaro J. ;

Liu, Chih Long ;

Kohrt, Holbrook E. ;

Houot, Roch ;

Goldstein, Matthew J. ;

Zhao, Shuchun ;

Natkunam, Yasodha ;

Advani, Ranjana H. ;

Gascoyne, Randy D. ;

Briones, Javier ;

Tibshirani, Robert J. ;

Myklebust, June H. ;

Plevritis, Sylvia K. ;

Lossos, Izidore S. ;

Levy, Ronald .

BLOOD, 2011, 118 (05) :1350-1358

[4] Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study [J].

Bolen, Christopher R. ;

Klanova, Magdalena ;

Trneny, Marek ;

Sehn, Laurie H. ;

He, Jie ;

Tong, Jing ;

Paulson, Joseph N. ;

Kim, Eugene ;

Vitolo, Umberto ;

Rocco, Alice Di ;

Fingerle-Rowson, Guenter ;

Nielsen, Tina ;

Lenz, Georg ;

Oestergaard, Mikkel Z. .

HAEMATOLOGICA, 2020, 105 (09) :2298-2307

[5]

Brousse N, 2017, WHO Classification of Tumours, P481

[6] Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma [J].

Bu, Rong ;

Hussain, Azhar R. ;

Al-Obaisi, Khadija A. S. ;

Ahmed, Maqbool ;

Uddin, Shahab ;

Al-Kuraya, Khawla S. .

LEUKEMIA & LYMPHOMA, 2014, 55 (02) :415-424

[7] Using Gene Expression Profiling to Move Beyond MYC/BCL2 Rearrangements in High-Grade Lymphoma [J].

Chan, Wing C. .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (03) :175-+

[8] Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes [J].

Chapuy, Bjoern ;

Stewart, Chip ;

Dunford, Andrew J. ;

Kim, Jaegil ;

Kamburov, Atanas ;

Redd, Robert A. ;

Lawrence, Mike S. ;

Roemer, Margaretha G. M. ;

Li, Amy J. ;

Ziepert, Marita ;

Staiger, Annette M. ;

Wala, Jeremiah A. ;

Ducar, Matthew D. ;

Leshchiner, Ignaty ;

Rheinbay, Ester ;

Taylor-Weiner, Amaro ;

Coughlin, Caroline A. ;

Hess, Julian M. ;

Pedamallu, Chandra S. ;

Livitz, Dimitri ;

Rosebrock, Daniel ;

Rosenberg, Mara ;

Tracy, Adam A. ;

Horn, Heike ;

van Hummelen, Paul ;

Feldman, Andrew L. ;

Link, Brian K. ;

Novak, Anne J. ;

Cerhan, James R. ;

Habermann, Thomas M. ;

Siebert, Reiner ;

Rosenwald, Andreas ;

Thorner, Aaron R. ;

Meyerson, Matthew L. ;

Golub, Todd R. ;

Beroukhim, Rameen ;

Wulf, Gerald G. ;

Ott, German ;

Rodig, Scott J. ;

Monti, Stefano ;

Neuberg, Donna S. ;

Loeffler, Markus ;

Pfreundschuh, Michael ;

Truemper, Lorenz ;

Getz, Gad ;

Shipp, Margaret A. .

NATURE MEDICINE, 2018, 24 (05) :679-+

[9] A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy [J].

Choi, William W. L. ;

Weisenburger, Dennis D. ;

Greiner, Timothy C. ;

Piris, Miguel A. ;

Banham, Alison H. ;

Delabie, Jan ;

Braziel, Rita M. ;

Geng, Huimin ;

Iqbal, Javeed ;

Lenz, Georg ;

Vose, Julie M. ;

Hans, Christine P. ;

Fu, Kai ;

Smith, Lynette M. ;

Li, Min ;

Liu, Zhongfeng ;

Gascoyne, Randy D. ;

Rosenwald, Andreas ;

Ott, German ;

Rimsza, Lisa M. ;

Campo, Elias ;

Jaffe, Elaine S. ;

Jaye, David L. ;

Staudt, Louis M. ;

Chan, Wing C. .

CLINICAL CANCER RESEARCH, 2009, 15 (17) :5494-5502

[10] Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue [J].

Ciavarella, S. ;

Vegliante, M. C. ;

Fabbri, M. ;

De Summa, S. ;

Melle, F. ;

Motta, G. ;

De Iuliis, V. ;

Opinto, G. ;

Enjuanes, A. ;

Rega, S. ;

Gulino, A. ;

Agostinelli, C. ;

Scattone, A. ;

Tommasi, S. ;

Mangia, A. ;

Mele, F. ;

Simone, G. ;

Zito, A. F. ;

Ingravallo, G. ;

Vitolo, U. ;

Chiappella, A. ;

Tarella, C. ;

Gianni, A. M. ;

Rambaldi, A. ;

Zinzani, P. L. ;

Casadei, B. ;

Derenzini, E. ;

Loseto, G. ;

Pileri, A. ;

Tabanelli, V. ;

Fiori, S. ;

Rivas-Delgado, A. ;

Lopez-Guillermo, A. ;

Venesio, T. ;

Sapino, A. ;

Campo, E. ;

Tripodo, C. ;

Guarini, A. ;

Pileri, S. A. .

ANNALS OF ONCOLOGY, 2018, 29 (12) :2363-2370

← 1 2 3 4 5 6 7 →